Severe autoimmune diabetes is a form of diabetes caused by the immune system attacking and progressively destroying the insulin-producing beta cells of the pancreas. In adults, a common clinical presentation is Latent Autoimmune Diabetes in Adults (LADA). Unlike classic type 1 diabetes, LADA usually develops more slowly and does not initially require insulin for glycemic control, generally for at least the first six months after diagnosis. Because it can resemble type 2 diabetes (T2DM), it is frequently misdiagnosed, delaying appropriate treatment.
LADA shares genetic, immunological, and metabolic characteristics with both type 1 and type 2 diabetes. A major distinguishing feature is the presence of pancreatic autoantibodies, particularly glutamic acid decarboxylase antibodies (GADA). Other antibodies, including islet antigen-2 (IA-2) and zinc transporter 8 (ZnT8) antibodies, may also be detected. As autoimmune destruction progresses, insulin production declines, reflected by increasingly low C-peptide levels.
When insulin production becomes severely impaired, patients develop classic symptoms of insulin deficiency. Rapid, unexplained weight loss can occur despite normal or increased food intake because glucose cannot enter cells efficiently for energy. High blood glucose also causes polyuria and polydipsia, resulting in frequent urination, excessive thirst, and dehydration. Other symptoms may include nocturia, fatigue, blurred or changing vision, and tingling or numbness in the feet. Some individuals, however, have few or no noticeable symptoms and are identified through routine blood testing.
A particularly serious complication is diabetic ketoacidosis (DKA). When there is insufficient insulin, the body rapidly breaks down fat, producing acidic substances called ketones. Severe ketone accumulation can make the blood dangerously acidic and requires urgent medical treatment. As autoimmune diabetes progresses and endogenous insulin production becomes very low or undetectable, daily insulin therapy through injections or an insulin pump becomes essential for survival.
Several factors should increase suspicion of LADA in an adult with newly diagnosed hyperglycemia. A personal or family history of autoimmune disease, such as autoimmune thyroid disease, celiac disease, or vitiligo, is particularly important. People with LADA may also have other autoimmune conditions. Research has identified associations with factors such as low birth weight, smoking, alcohol consumption, and intake of sugar-sweetened beverages, although these factors are not diagnostic by themselves.
Recognizing LADA early is important because treatment and monitoring differ from those used for typical T2DM. When clinical features suggest autoimmune diabetes, testing for pancreatic autoantibodies and C-peptide can help clarify the diagnosis. Early recognition allows healthcare professionals to monitor declining insulin production, reduce the risk of metabolic emergencies, and introduce insulin therapy when it becomes necessary.Characteristics of Severe Autoimmune Diabetes in Adults
